|
Showing 1 - 3 of
3 matches in All Departments
Twenty-five years ago, micro- and nanotechnology were barely in
their infancy. Today, technological advancements at the lower end
of the nanoscale have radically changed the field of medicine,
allowing for innovative and more personalized approaches to
numerous pathologies. The initial cascade of advancements was
triggered by the herculean efforts of a few pioneers in the field.
Dr. Mauro Ferrari is one such visionary; his work over the past two
decades has set the stage for medical innovation through
nanotechnology. Written by world-renowned experts in the field,
this book pays tribute to Dr. Mauro Ferrari's vast contribution to
the field of nanotechnology and nanomedicine. It covers the
multifaceted and fundamental aspects of biomedical research,
including technological innovation, ethics, patient advocacy, and
clinical translation, all areas where Dr. Ferrari's contribution
has been and continue to be fundamental. Additionally, it presents
recent advances in micro- and nanotechnologies. Chapter 2 and
Chapters 9 through 27 were originally published in Biomedical
Microdevices in the Topical Collection "Biomedical
Micro-Nanotechnologies toward Translation"
Less than twenty years ago photolithography and medicine were total
strangers to one another. They had not yet met, and not even
looking each other up in the classi?eds. And then, nucleic acid
chips, micro?uidics and microarrays entered the scene, and rapidly
these strangers became indispensable partners in biomedicine.
Asrecentlyastenyearsagothenotionofapplyingnanotechnologytothe?ghtagainstd-
ease was dominantly the province of the ?ction writers. Thoughts of
nanoparticle-vehicled
deliveryoftherapeuticalstodiseasedsiteswereanexerciseinscienti?csolitude,andgrounds
for questioning one's ability to think "like an established
scientist". And today we have nanoparticulate paclitaxel as the
prime option against metastatic breast cancer, proteomic
pro?lingdiagnostictoolsbasedontargetsurfacenanotexturing,nanoparticlecontrastagents
for all radiological modalities, nanotechnologies embedded in
high-distribution laboratory equipment, and no less than 152 novel
nanomedical entities in the regulatory pipeline in the US alone.
Thisisatransformingimpact,byanymeasure,withclearevidenceoffurtheracceleration,
supported by very vigorous investments by the public and private
sectors throughout the world. Even joining the dots in a most
conservative, linear fashion, it is easy to envision scenarios of
personalized medicine such as the following: patient-speci?c
prevention supplanting gross, faceless intervention strategies;
early detection protocols identifying signs of developing disease
at the time when the disease is most easily subdued; personally
tailored intervention strategies that are so routinely and
inexpensively realized, that access to them can be secured by
everyone; technologies allowing for long lives in the company of
disease, as good neighbors, without impairment of the quality of
life itself.
Less than twenty years ago photolithography and medicine were total
strangers to one another. They had not yet met, and not even
looking each other up in the classi?eds. And then, nucleic acid
chips, micro?uidics and microarrays entered the scene, and rapidly
these strangers became indispensable partners in biomedicine.
Asrecentlyastenyearsagothenotionofapplyingnanotechnologytothe?ghtagainstd-
ease was dominantly the province of the ?ction writers. Thoughts of
nanoparticle-vehicled
deliveryoftherapeuticalstodiseasedsiteswereanexerciseinscienti?csolitude,andgrounds
for questioning one's ability to think "like an established
scientist". And today we have nanoparticulate paclitaxel as the
prime option against metastatic breast cancer, proteomic
pro?lingdiagnostictoolsbasedontargetsurfacenanotexturing,nanoparticlecontrastagents
for all radiological modalities, nanotechnologies embedded in
high-distribution laboratory equipment, and no less than 152 novel
nanomedical entities in the regulatory pipeline in the US alone.
Thisisatransformingimpact,byanymeasure,withclearevidenceoffurtheracceleration,
supported by very vigorous investments by the public and private
sectors throughout the world. Even joining the dots in a most
conservative, linear fashion, it is easy to envision scenarios of
personalized medicine such as the following: patient-speci?c
prevention supplanting gross, faceless intervention strategies;
early detection protocols identifying signs of developing disease
at the time when the disease is most easily subdued; personally
tailored intervention strategies that are so routinely and
inexpensively realized, that access to them can be secured by
everyone; technologies allowing for long lives in the company of
disease, as good neighbors, without impairment of the quality of
life itself.
|
You may like...
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
|